AlloVir Inc (ALVR): Earnings per share for the last twelve months

Corporate company logo of AlloVir (ALVR)

Amidst a fierce patent battle with global players, the rolling 12-month EPS chart helps assess the resilience of AlloVir, Inc. (ALVR). Meanwhile, -11.67 records a new level. Business efficiency is increasing due to bioreactor automation, which reduces the cost per therapy dose. Long-term agreements with specialized medical logistics providers ensure operational stability.

AlloVir, Inc. (ALVR) - Net earnings per share (EPS TTM) from 07/04/2022 to 03/29/2025

Summary analytical data breakdowns for AlloVir Inc (ALVR)

- stock price and consensus target price:
Stock Price AlloVir Bio|ALVR - Analyst Median Target
- stock exchange capitalization data:
Market Value AlloVir, Inc.|ALVR - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share AlloVir|ALVR - Book Capitalization|Market Value to Book Value Ratio allovir.com|ALVR - Company Total Asset Base
- debt obligations and liquidity statistics:
Total Debt to Capital AlloVir, Inc.|ALVR - Long-Term Debt to Capital|Short-Term Debt to Equity AlloVir Bio|ALVR - Company Debts|Debt to Book Capitalization Ratio AlloVir, Inc.|ALVR - Company Long-Term Debt|Company Short-Term Debt AlloVir|Quick Liquidity Indicator allovir.com
- earnings and valuation multiples indicators:
ALVR - Company Net Income|Projected Future Earnings AlloVir, Inc.|ALVR - Business Payback Period|Future Price to Earnings AlloVir Bio|ALVR - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio AlloVir, Inc.|ALVR - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) AlloVir|ALVR - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months allovir.com|ALVR - Earnings per share growth this year|Earnings growth forecast for next year AlloVir, Inc.
- sales and revenue data:
ALVR - Company Sales|Company Future Sales Volume AlloVir Bio|ALVR - Price-to-Revenue Coefficient|Forward P/S Multiple AlloVir, Inc.
Fundamental company valuation:ALVR - allovir.com
Manufactured products of AlloVir Bio

AlloVir, Inc. (ALVR) minimizes capital expenditures by outsourcing production and testing to third-party contractors. The eps_ttm_co metric digitizes the final profit allocated per share over a trailing twelve-month period, excluding the impact of issuance volume. By analyzing the eps TTM history on the GURU.Markets platform, an investor can see the real efficiency of this outsourcing model. The stability of the line confirms the manageability of operating expenses. The indicator's dynamics determine the investment attractiveness and the risk of capital freeze.

Competitor analysis for AlloVir, Inc.

Gilead Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Therapeutics Inc CDTX|Novavax (NVAX) - Earnings per share for the last twelve months|CureVac NV - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Net earnings per share (EPS TTM) Vir Corp|Earnings per share for the last twelve months SIGA Technologies, Inc. (SIGA)|Net earnings per share for the last four quarters emergentbiosolutions.com|Net earnings per share (EPS TTM) AVIR (Atea Pharmaceuticals, Inc.)|Net earnings per share (EPS TTM) Invivyd Inc IVVD|ENTA - Earnings per share for the last twelve months|INO: Earnings per share for the last twelve months|HilleVax, Inc. (HLVX) - Earnings per share for the last twelve months|KLRS (kalaristx.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Dyadic International Inc|Net earnings per one share for the last twelve months NanoViricides Corp NNVC|Net earnings per share for the last 12 months TLPH (Talphera Corp)|Earnings per share for the last twelve months COCP (Cocrystal Pharma Corp)|Net earnings per share (EPS TTM) TRAW (Traws Pharma)|Net earnings per share for the last four quarters Dogwood Therapeutics Inc. (DWTX)|QLGN - Earnings per share for the last twelve months|Earnings per share for the trailing year VBIV (VBI Vaccines Inc.)|VIRI (virios.com) - Net earnings per share for the last 12 months|Vaxart - Earnings per share for the trailing year